Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea · Delayed Price · Currency is KRW 23,100
0.00 (0.00%)
Aug 8, 2025, 3:30 PM KST
SolarWinds Revenue
Orum Therapeutics had revenue of 2.95M KRW in the quarter ending March 31, 2025, a decrease of -80.88%. This brings the company's revenue in the last twelve months to 20.89B, down -84.57% year-over-year. In the year 2024, Orum Therapeutics had annual revenue of 20.91B, down -84.56%.
Revenue (ttm)
20.89B
Revenue Growth
-84.57%
P/S Ratio
23.29
Revenue / Employee
1.04B
Employees
20
Market Cap
486.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.91B | -114.51B | -84.56% |
| Dec 31, 2023 | 135.42B | 135.34B | 178,270.49% |
| Dec 31, 2022 | 75.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition